Evaluation of efficacy of alemtuzumab in 5 patients with aplastic anemia and/or myelodysplastic neoplasm

por Füreder, Wolfgang, Cerny-Reiterer, Sabine, Sperr, Wolfgang R., Müllauer, Leonhard, Jäger, Eva, Schwarzinger, Ilse, Geissler, Klaus, Valent, Peter
Publicado 2016

Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?

por Schulenburg, Axel, Blatt, Katharina, Cerny-Reiterer, Sabine, Sadovnik, Irina, Herrmann, Harald, Marian, Brigitte, Grunt, Thomas W, Zielinski, Christoph C, Valent, Peter
Publicado 2015

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia

por Warsch, Wolfgang, Grundschober, Eva, Berger, Angelika, Gille, Lars, Cerny-Reiterer, Sabine, Tigan, Anca-Sarmiza, Hoelbl-Kovacic, Andrea, Valent, Peter, Moriggl, Richard, Sexl, Veronika
Publicado 2012

Overexpression of primary microRNA 221/222 in acute myeloid leukemia

por Rommer, Anna, Steinleitner, Katarina, Hackl, Hubert, Schneckenleithner, Christine, Engelmann, Maria, Scheideler, Marcel, Vlatkovic, Irena, Kralovics, Robert, Cerny-Reiterer, Sabine, Valent, Peter, Sill, Heinz, Wieser, Rotraud
Publicado 2013

FLAG-induced remission in a patient with acute mast cell leukemia (MCL) exhibiting t(7;10)(q22;q26) and KIT D816H()

por Valent, Peter, Blatt, Katharina, Eisenwort, Gregor, Herrmann, Harald, Cerny-Reiterer, Sabine, Thalhammer, Renate, Müllauer, Leonhard, Hoermann, Gregor, Sadovnik, Irina, Schwarzinger, Ilse, Sperr, Wolfgang R., Mannhalter, Christine, Horny, Hans-Peter
Publicado 2013

Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia (AML)

por Herrmann, Harald, Blatt, Katharina, Shi, Junwei, Gleixner, Karoline V., Cerny-Reiterer, Sabine, Müllauer, Leonhard, Vakoc, Christopher R., Sperr, Wolfgang R., Horny, Hans-Peter, Bradner, James E., Zuber, Johannes, Valent, Peter
Publicado 2012

Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56(bright) NK cell subpopulations in patients with acute myeloid leukemia and supports their acti...

por Cuapio, Angélica, Post, Mirte, Cerny-Reiterer, Sabine, Gleixner, Karoline V., Stefanzl, Gabriele, Basilio, Jose, Herndlhofer, Susanne, Sperr, Wolfgang R., Brons, Nicolaas H.C., Casanova, Emilio, Zimmer, Jacques, Valent, Peter, Hofer, Erhard
Publicado 2016

Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis

por Grebien, Florian, Hantschel, Oliver, Wojcik, John, Kaupe, Ines, Kovacic, Boris, Wyrzucki, Arkadiusz M., Gish, Gerald D., Cerny-Reiterer, Sabine, Koide, Akiko, Beug, Hartmut, Pawson, Tony, Valent, Peter, Koide, Shohei, Superti-Furga, Giulio
Publicado 2011

Identification of heat shock protein 32 (Hsp32) as a novel target in acute lymphoblastic leukemia

por Cerny-Reiterer, Sabine, Meyer, Renata A., Herrmann, Harald, Peter, Barbara, Gleixner, Karoline V., Stefanzl, Gabriele, Hadzijusufovic, Emir, Pickl, Winfried F., Sperr, Wolfgang R., Melo, Junia V., Maeda, Hiroshi, Jäger, Ulrich, Valent, Peter
Publicado 2014

The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells

por Stefanzl, Gabriele, Berger, Daniela, Cerny-Reiterer, Sabine, Blatt, Katharina, Eisenwort, Gregor, Sperr, Wolfgang R., Hoermann, Gregor, Lind, Karin, Hauswirth, Alexander W., Bettelheim, Peter, Sill, Heinz, Melo, Junia V., Jäger, Ulrich, Valent, Peter
Publicado 2017

A Target-Disease Network Model of Second-Generation BCR-ABL Inhibitor Action in Ph+ ALL

por Rix, Uwe, Colinge, Jacques, Blatt, Katharina, Gridling, Manuela, Remsing Rix, Lily L., Parapatics, Katja, Cerny-Reiterer, Sabine, Burkard, Thomas R., Jäger, Ulrich, Melo, Junia V., Bennett, Keiryn L., Valent, Peter, Superti-Furga, Giulio
Publicado 2013

Long-term treatment with imatinib results in profound mast cell deficiency in Ph+ chronic myeloid leukemia

por Cerny-Reiterer, Sabine, Rabenhorst, Anja, Stefanzl, Gabriele, Herndlhofer, Susanne, Hoermann, Gregor, Müllauer, Leonhard, Baumgartner, Sigrid, Beham-Schmid, Christine, Sperr, Wolfgang R, Mannhalter, Christine, Sill, Heinz, Linkesch, Werner, Arock, Michel, Hartmann, Karin, Valent, Peter
Publicado 2014

Identification of bromodomain-containing protein 4 (BRD4) as a novel marker and epigenetic target in mast cell leukemia

por Wedeh, Ghaith, Cerny-Reiterer, Sabine, Eisenwort, Gregor, Herrmann, Harald, Blatt, Katharina, Hadzijusufovic, Emir, Sadovnik, Irina, Müllauer, Leonhard, Schwaab, Juliana, Hoffmann, Thomas, Bradner, James E., Radia, Deepti, Sperr, Wolfgang R., Hoermann, Gregor, Reiter, Andreas, Horny, Hans-Peter, Zuber, Johannes, Arock, Michel, Valent, Peter
Publicado 2015

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia

por Blatt, Katharina, Menzl, Ingeborg, Eisenwort, Gregor, Cerny-Reiterer, Sabine, Herrmann, Harald, Herndlhofer, Susanne, Stefanzl, Gabriele, Sadovnik, Irina, Berger, Daniela, Keller, Alexandra, Hauswirth, Alexander, Hoermann, Gregor, Willmann, Michael, Rülicke, Thomas, Sill, Heinz, Sperr, Wolfgang R., Mannhalter, Christine, Melo, Junia V., Jäger, Ulrich, Sexl, Veronika, Valent, Peter
Publicado 2018

Standards and Impact of Hematopathology in Myelodysplastic Syndromes (MDS)

por Valent, Peter, Orazi, Attilio, Büsche, Guntram, Schmitt-Gräff, Annette, George, Tracy I., Sotlar, Karl, Streubel, Berthold, Beham-Schmid, Christine, Cerny-Reiterer, Sabine, Krieger, Otto, van de Loosdrecht, Arjan, Kern, Wolfgang, Ogata, Kiyoyuki, Wimazal, Friedrich, Csomor, Judit, Várkonyi, Judit, Sperr, Wolfgang R., Werner, Martin, Kreipe, Hans, Hans-Peter, Horny
Publicado 2010